Abstract. Under complete linkage disequilibrium (LD), robust tests often have greater power than Pearson's chi-square test and trend tests for the analysis of case-control genetic association studies. Robust statistics have been used in candidate-gene and genome-wide association studies (GWAS) when the genetic model is unknown. We consider here a more general incomplete LD model, and examine the impact of penetrances at the marker locus when the genetic models are defined at the disease locus. Robust statistics are then reviewed and their efficiency and robustness are compared through simulations in GWAS of 300,000 markers under the incomplete LD model. Applications of several robust tests to the Wellcome Trust Case-Control Consortium [Nature 447 (2007) 661-678] are presented.
INTRODUCTION
Genome-wide association studies (GWAS) have been used to detect true associations between 100,000 to 500,000 genetic markers (single-nucleotide polymorphisms-SNPs) and common or complex diseases (e.g., Klein et al., 2005; Sladek et al., 2007; WTCCC, 2007) . Currently, up to a million SNPs are used in GWAS. A simple and initial analysis of GWAS is a genome-wide scan, in which a statistical test is applied to detect association one SNP at a time. Test statistics and/or their p-values are obtained for all SNPs and ranked in order of their statistical significance. After all SNPs are ranked, a prespecified small proportion of SNPs from the topranked SNPs (or SNPs with p-values less than a prespecified genome-wide threshold level) is selected for further, more focused analyses, for example, haplotype analysis, multi-marker analysis, fine mapping, imputation and independent replication studies (see Hoh and Ott, 2003; Marchini, Donnelly and Cardon, 2005; Schaid et al., 2005) . The genome-wide scan has also been shown to be cost-effective in two-stage designs for GWAS, in which additional subjects are genotyped in the second stage for a small portion of selected SNPs in the first stage (see Elston, Lin and Zheng, 2007; Thomas et al., 2009) . We focus on robust tests for GWAS in the single stage designs.
Since only a small portion of top-ranked SNPs is selected in genome-wide scans, it is important that the probability of at least one SNP with true association being selected is high, for example, greater than 80% (Zaykin and Zhivotovsky, 2005; Gail et al., 2008) . The probability that a SNP with true association is detected, confirmed and replicated in later more focused analyses is often smaller. Hence, one of the goals of genome-wide scans is to rank the SNPs with true associations as near to the top as possible. Zaykin and Zhivotovsky (2005) showed that the factors that mainly affect the rankings of true SNPs include the total number of SNPs, the number of SNPs with true associations, the genetic effects (genotype relative risks or odds ratios), the sample size, power of the association test used, and linkage disequilibrium (LD) between SNPs and the functional locus (the true unknown disease locus). Most of the above factors are determined by the study design, except the power of the test for association. The common association tests include Pearson's chisquared test (Pearson's test, for short), the CochranArmitage trend tests (CATTs) and the allelic test. Three CATTs are available depending on the underlying genetic model (the mode of inheritance of the disease locus). Common genetic models include recessive, additive, multiplicative and dominant models. Overdominant and underdominant models may also be used, but they are less common. The allelic test has performance similar to that of the CATT under the additive model when the Hardy-Weinberg equilibrium proportions hold (Sasieni, 1997; Guedj, Nuel and Prum, 2008) . Thus, the allelic test is not considered here.
Intuitively, the most powerful test should be used in genome-wide scans. For common and complex diseases, it is possible that there are multiple functional loci with different genetic models, in particular, for GWAS. The power of an association test depends on the underlying genetic models of the functional loci, which, however, are unknown. They could be any of the four common genetic models or none of them. In addition, imperfect LD between functional and marker loci can modify the underlying genetic model, further increasing uncertainty. In this case, there is no uniformly most powerful test for a genome-wide scan. It is known that the most efficient CATT is available when the genetic model is known (Sasieni, 1997; Freidlin et al., 2002) . When the genetic model is unknown, using a single CATT is not robust across a family of genetics models. Therefore, in this situation, more robust tests have been proposed for both candidate-gene studies and genome-wide scans (Freidlin et al., 2002; Sladek et al., 2007; Zheng and Ng, 2008; Gonzalez et al., 2008; Joo et al., 2009) . The performance of the robust test statistics has been studied under the perfect LD model, that is, the SNP is the same as the functional locus (see more discussion later). This is, however, a strong assumption for GWAS. In particular, when one of the models embedded into a robust test holds at the functional locus, it remains unmodified at the marker locus. Therefore, it is not surprising that robust tests based on the maximum of test statistics over common genetic models often provide greater power than Pearson's test and CATTs. However, when LD is imperfect, the induced penetrance values at the marker are weighted averages of the causal penetrances, where the weights are functions of LD. Thus, the imperfect LD will change certain models, such as the dominant or the recessive models, so that the heterozygote penetrance will have an intermediate value between those for the homozygotes. Therefore, it is important to investigate not only the exact form of such penetrance modifications, but also its impact on the performance of the robust tests for association.
In this article we consider a general LD model with the standardized LD parameter, D ′ (Lewontin, 1964) , and study the properties of the penetrances defined at the marker locus given the genetic model defined at the functional locus. In addition to reviewing some common robust tests for case-control association studies, we also compare their performance under this general model with a varying D ′ . Using robust tests when there is imperfect LD has not been studied perviously. The perfect LD case, where the marker and the disease loci coincide, can be obtained as a special case at D ′ = 1, with an additional requirement of equality of allele frequencies at the marker and the disease locus. This implies a perfect correlation between the alleles at the two loci. Under this general model, we also examine the effectiveness and robustness of the genetic model selection procedure (Zheng and Ng, 2008) . Simulation studies are conducted to compare the efficiency robustness of various robust tests under this general model for genome-wide scans of 300,000 SNPs. Applications of robust tests are presented using real data from a GWAS (WTCCC, 2007) .
The rest of the article is organized as follows. In Section 2 we introduce notation, the case-control data and different genetic models. The Hardy-Weinberg disequilibrium coefficient and its use to detect the underlying genetic model is given in Section 3. Various robust tests for candidate-gene analysis and GWAS will be reviewed under the perfect LD model in Section 4. Section 5 presents numerical results based on the simulation studies. The performance of the model selection procedure under the general LD model will be reported. Comparison of several robust tests in analyzing genome-wide data is also presented. Applications to real data are given in Section 6. Discussion and conclusions are given in the final section.
GENETIC MODELS

Notation and Data
Consider a case-control association study with r cases and s controls and a SNP with alleles A and B. Denote the population frequencies of the alleles by Pr(B) = p and Pr(A) = p c = 1 − p. The three genotypes of the SNP are denoted by G 0 = AA, G 1 = AB, and G 2 = BB, with the population frequencies Pr(G i ) = g i for i = 0, 1, 2. When the HardyWeinberg equilibrium (HWE) proportions hold in the population, (g 0 , g 1 , g 2 ) = (p 2 c , 2pp c , p 2 ). The casecontrol data for the SNP can be displayed in a 2 × 3 contingency table with the rows corresponding to case or control groups and the columns to the three genotypes. The genotype counts for (G 0 , G 1 , G 2 ) in cases and controls are denoted by (r 0 , r 1 , r 2 ) and (s 0 , s 1 , s 2 ), respectively. The genotype counts follow multinomial distributions: (r 0 , r 1 , r 2 ) ∼ Mul(r; p 0 , p 1 , p 2 ) and (s 0 , s 1 , s 2 ) ∼ Mul(s; q 0 , q 1 , q 2 ), where p i = Pr(G i |case) and q i = Pr(G i |control) for i = 0, 1, 2. Under the null hypothesis of no association, H 0 :
Denote the penetrance of the SNP by f i = Pr(case| G i ), and the disease prevalence by k = Pr(case).
For simplicity, we assume in this section there is only one functional locus. Therefore, there is only one genetic model.
Perfect LD Model
Under this model, the SNP is also the functional locus with equal allele frequencies. The penetrances f i , i = 0, 1, 2, defined earlier are also penetrances of the functional locus. Genotype relative risks (GRRs) are defined by λ i = f i /f 0 for i = 1, 2, where f 0 is the reference penetrance. Under the alternative hypothesis, allele B is the risk allele if the probability of having the disease increases with the number of B alleles in the genotype. That is, f 2 ≥ f 1 ≥ f 0 and f 2 > f 0 . These two constraints define a family of constrained genetic models, which contains four commonly used genetic models:
We refer to Λ as the constrained space for genetic models when the risk allele is known. The null hypothesis corresponds to H 0 : λ 1 = λ 2 = 1. The genetic model is recessive if λ 1 = 1, additive if λ 1 = (1 + λ 2 )/2, multiplicative if λ 1 = λ 1/2 2 , and dominant if λ 1 = λ 2 . Let λ 2 = λ for some λ ≥ 1. Then λ 1 can be calculated using λ value under one of the four genetic models. The first three letters of each model are used to indicate the genetic model in the following, for example, REC stands for the recessive model.
Note that Λ does not contain overdominant or underdominant models, which occurs when λ 1 ≥ λ 2 ≥ 1, λ 1 > 1 and λ 2 ≥ 1 ≥ λ 1 , λ 2 > λ 1 , respectively. These two models are less common compared to the other four genetic models reviewed here.
Incomplete LD Model
Under this model, the SNP of interest is not the functional locus. Suppose the functional locus also has two alleles, denoted by a and b, with the population frequencies Pr(b) = q and Pr(a) = q c = 1 − q. Assume that the SNP with alleles A and B is associated with the disease through LD with the functional locus with alleles a and b. Table 1 represents the joint probabilities of the two loci, in which D = Pr(Aa)− Pr(A) Pr(a) measures LD between the SNP and the functional locus. When D = 0, they are in linkage equilibrium. An association between the SNP and a disease can be established when |D| > 0 and when the two loci are linked.
There are two commonly used measures of the relationship between the SNP and the functional locus: D ′ and the correlation between the alleles A and a. Denote p Aa = Pr(Aa), p Ab = Pr(Ab), p Ba = 
Pr(Ba), and Lewontin (1964) is defined as
When the SNP is identical to the functional locus (i.e., A ≡ a, B ≡ b and p ≡ q), p Bb = p, p Aa = p c , and
can be reached when the SNP is not identical to the functional locus (e.g., when p = q). The correlation between the two alleles is defined as (Weir, 1996) Corr
Note that the correlation reaches its maximum value only when p = q. The LD model is complete if |D ′ | = 1 and perfect if | Corr(A, a)| = 1. In this article we assume the two loci have the same allele frequencies. 
The definition of a genetic model under the imperfect LD model differs from that under the perfect LD model. Denote the genotypes at the functional locus by G * 0 = aa, G * 1 = ab and G * 2 = bb. The penetrance of the functional locus is given by f * i = Pr(case|G * i ) for i = 0, 1, 2. Accordingly, define GRRs by
The penetrance of the SNP is the same as before and still denoted by
where t is transpose and P * = (Pr(G * i |G j )) 3×3 and P = (Pr(G i |G * j )) 3×3 are 3 × 3 transition matrices. Then we have
Under the perfect LD model, the two transition matrices are identity matrices P * = P = I. The conditional probabilities in (2) can be obtained using
under the Hardy-Weinberg proportions at both SNP and functional locus, which are given in Table 2 . Note that these are functions of the four haplotype frequencies. The conditional probabilities in (3) can be obtained similarly, and can also be found in Nielsen and Weir (1999) and Hanson et al. (2006) , Table 3 .
Properties of Genetic Models under the Imperfect LD Model
We defined genetic models using penetrances (f 0 , f 1 , f 2 ) at the SNP of interest. Under the imperfect LD model, the genetic model should be defined at the functional locus using (f * 0 , f * 1 , f * 2 ). Thus, the REC, ADD, MUL or DOM models correspond to
, or λ * 1 = λ * 2 , respectively. A constrained family of possible genetic models at the functional locus is given by
Note that Λ and Λ * are different under the imperfect LD model, and they are linked by the two transition matrices in (2) and (3). Under the imperfect LD model, applying Table 2 
we have
The true disease model at the functional locus, defined using (λ * 1 , λ * 2 ), is unknown. We study properties of the penetrances (f 0 , f 1 , f 2 ) or GRRs (λ 1 , λ 2 ) defined at the SNP given (λ * 1 , λ * 2 ). Theorem 2.1. Under the imperfect LD model with
and (5) to (7), we obtain
The proof of the second claim is trivial using the above two expressions and that, from Table 1 , all F i , i = 1, 2, 3, 4, are positive. Theorem 2.1 shows that when the GRRs are constrained in Λ * at the functional locus, they are also constrained to a subset of Λ at the SNP when |D ′ | < 1. In addition, when the true disease model is either REC or DOM at the functional locus, it is no longer REC or DOM at the SNP, respectively. They are "closer" to the ADD/MUL models. The implication of this finding is that one will not see a pure DOM or REC model at the marker locus if the constrained model space Λ * is considered at the functional locus. It also provides a rationale for the genetic model selection approach (Zheng and Ng, 2008) in that an ADD/MUL is always chosen unless there is strong evidence to indicate the REC or DOM models.
Even though the REC (or DOM) model at the functional locus is no longer retained at the SNP when |D ′ | < 1, the ADD (or MUL) model is retained. Dividing (8) and (9) by f 0 , we obtain
Using (5) to (7) 
The above two equations lead directly to the following result.
Theorem 2.2. Under the imperfect LD model with |D ′ | < 1, when the genetic model is ADD (λ * 1 = (1 + λ * 2 )/2) or MUL (λ * 2 = λ * 2 1 ) at the functional locus, the same model is retained at the marker locus. table similar to Table 2 , the REC or DOM models at the marker locus would correspond to the underdominant or overdominant models at the functional locus, respectively.
THE HARDY-WEINBERG DISEQUILIBRIUM COEFFICIENT AND GENETIC MODEL SELECTION
The Hardy-Weinberg disequilibrium (HWD) coefficient in cases or between cases and controls has been used to detect association (Nielsen, Ehm and Weir, 1998; Zaykin and Nielsen, 2000; Song and Elston, 2006 ). In addition, it can also be used to detect the underlying genetic model at the marker locus (Wittke- Thompson, Pluzhnikov and Cox, 2005; Zheng and Ng, 2008) . In this section we first review the HWD coefficient and how it can be used to detect the genetic model at the SNP of interest. Then we study whether it can still be used to detect the genetic model which is defined at the functional locus under the imperfect LD model.
Using the notation in Section 1, the HWD coefficient at the SNP with alleles A and B is given by (Weir, 1996) 
In cases and controls, it is denoted by ∆ 1 and ∆ 0 , respectively, and given by 
Using the signs of (∆ 1 , ∆ 0 ), Zheng and Ng (2008) divided Λ in (1) into four mutually exclusive regions R 1 to R 4 . The signs in the four regions are 
under H 0 and referred to as the HWD trend test (HWDTT) (Song and Elston, 2006) . It is used to select a genetic model (Zheng and Ng, 2008) . Given that B is the risk allele, the ADD (or MUL) model is chosen unless there is strong evidence to indicate a REC model or a DOM model. When Z HWDTT > 1.645, the REC model is selected; when Z HWDTT < −1.645, the DOM model is selected.
Under the imperfect LD model, using (11) and (10), (12) and (13) can be written as
Comparing the above (∆ 1 , ∆ 0 ) with (12) and (13), we see that the signs of (∆ 1 , ∆ 0 ) do not change when the genetic model is defined at the functional locus. Hence, the model selection procedure of Zheng and Ng (2008) can still be used.
ROBUST TESTS
Pearson's Test and CATTs
Given the case-control data for a single SNP, (r 0 , r 1 , r 2 ) and (s 0 , s 1 , s 2 ), denote n i = r i + s i for i = 0, 1, 2 and n = n 0 + n 1 + n 2 . Pearson's test can be written as
which asymptotically follows a chi-squared distribution with 2 degrees of freedom (df) under H 0 . The CATT with a score x ∈ [0, 1] is given by
where (x 0 , x 1 , x 2 ) = (0, x, 1). Under H 0 , Z x asymptotically follows the standard normal distribution N (0, 1) for a given x. Optimal scores for REC, ADD/MUL and DOM models are x = 0, 1/2 and 1. When the genetic model is unknown, Z 1/2 is often used. There is a trade-off between T χ 2 and Z x with x = 1/2. Pearson's test is more robust but less powerful, in particular, under the ADD or DOM models, while the trend test is more powerful under the ADD or DOM models but less robust when the score x is misspecified. Pearson's test is identical to the trend test Z 2
x with x = (r 1 /n 1 − r 0 /n 0 )/(s 1 /n 1 − s 0 /n 0 ) (Yamada and Okada, 2009; Zheng, Joo and Yang, 2009 ). In practice, however, x is prespecified. Thus, this condition is rarely satisfied.
MAX
To avoid the trade-off between Pearson's test and the CATT, one approach is to consider maximum tests. A typical maximum test is given by (Freidlin et al., 2002; Sladek et al., 2007) MAX 3 = max{|Z 0 |, |Z 1/2 |, |Z 1 |}.
Other versions of maximum tests are also used, for example, MAX = sup x∈[0,1] |Z x | (Davies, 1977 (Davies, , 1987 , the maximum of three likelihood ratio tests under various genetic models (González et al., 2008) , and for a quantitative trait (Lettre, Lange and Hirschhorn, 2007) .
Computational aspects of maximum tests have been discussed by Conneely and Boehnke (2007) and Li et al. (2008a) . The empirical distribution of MAX 3 can be obtained from simulation using the joint multivariate normal distribution of the CATTs considering asymptotic null correlations among them (Freidlin et al., 2002) or from a parametric bootstrap procedure by generating data using (r 0 , r 1 , r 2 ) ∼ Mul(r; p 0 , p 1 , p 2 ) and (s 0 , s 1 , s 2 ) ∼ Mul(s; p 0 , p 1 , p 2 ), where p i = n i /n. A simpler algorithm to find the asymptotic and empirical null distributions of MAX 3 is recently proposed (Zang, Fung and Zheng, 2010) . The asymptotic null distribution of MAX 3 is a function of the minor allele frequency (MAF) of the SNP. In a genome-wide scan to rank a large number of SNPs, Li et al. (2008b) 
MIN2
An alternative approach used by WTCCC (2007) utilizes both Pearson's test and the CATT Z 1/2 . WTCCC (2007) proposed to use the minimum of the p-values of T χ 2 and Z 1/2 to scan all the SNPs. SNPs with the minimum p-value less than a threshold level were retained for further analyses. denoted the minimum of the two p-values by MIN2 = min{p T χ 2 , p Z 1/2 } and obtained its asymptotic null distribution and its p-value, denoted by p MIN2 . The key formula to find the distribution and p-value for MIN2 is the joint distribution of Pearson's test and Z 1/2 under H 0 , which is given by 
when t 1 < t 2 , and Pr(Z 2 1/2 < t 1 , T χ 2 < t 2 ) = 1 − exp(−t 2 /2) when t 1 > t 2 . Unlike MAX 3 , the asymptotic null distribution of MIN2 does not depend on the MAFs of SNPs. Hence, MIN2 itself can be used to rank all SNPs, which results in the same ranks as when the p-value of MIN2 is used. Joo et al. (2009) demonstrated that p MIN2 > MIN2, because Z 2 1/2 and T χ 2 are correlated under the alternative hypothesis. Thus, MIN2 itself cannot be used as the p-value.
The Genetic Model Selection (GMS) Procedure
The GMS procedure is an adaptive approach. It contains two phases. In phase 1 the underlying genetic model is detected using the value and sign of Z HWDTT (Song and Elston, 2006 ; see also Section 3). Once the model is selected (REC, ADD/MUL or DOM), in the second phase, the CATT optimal for the selected model is applied to test for association. For example, if the REC model is selected using the HWDTT, Z 0 would be used in phase 2 to test for association. Since the analyses in the two phases are correlated, Zheng and Ng (2008) derived the asymptotic null correlation for the GMS. This correlation is incorporated in the distribution of the test statistics to control for the Type I error. Like MIN2, computing the p-value of the GMS requires integrations. Like MAX 3 , the GMS can be used to rank SNPs . Using test statistics to directly rank SNPs is easier than using p-values of the GMS. Since the GMS depends on which allele is the risk allele or whether the minor allele is the risk allele, for each SNP, we first determine the risk allele (B is risk allele if Z 1/2 > 0). If the risk allele is B, then the above GMS can be applied. Otherwise, we can switch the two alleles and apply the above GMS.
Other Tests
Balding (2006) provided an excellent review of statistical methods for the analysis of association studies. Two other robust two-phase tests are also available that we do not include here. One feature of these methods is that the test statistics in two phases are asymptotically independent under H 0 (Zheng, Song and Elston, 2007, Zheng et al., 2008) . In this case, the second phase can be used as a "selfreplication," an idea proposed in van Steen et al. (2005) . Alternatively, the significance level α can be decomposed to (α 1 , α 2 ) such that α 1 α 2 = α, where α 1 is used for the phase 1 analysis and α 2 for the phase 2 analysis. The null hypothesis is rejected when analyses in both phases are significant at their corresponding levels. Choices of α 1 and α 2 with α 1 α = α in GWAS were discussed in Zheng, Song and Elston (2007) , . Another robust test is the constrained likelihood ratio test (LRT) (Wang and Sheffield, 2005) . It is similar to the LRT except that the alternative space is restricted to Λ − {(1, 1)}. The performance of the constrained LRT is similar to that of MAX 3 described above. Thus, we only consider MAX 3 here.
Why Robust Tests?
One of the reasons that we use robust tests in GWAS is that there might be multiple functional loci for a given disease. The modes of inheritance or genetic models may differ from one functional locus to the other. Another reason for using robust tests is the distortion of the actual genetic model at the marker locus due to incomplete LD, which further amplifies uncertainty about the model. Thus, robust tests are generally preferred. We use efficiency robustness to measure robustness (Gastwirth, 1985) . A test T 1 is said to have greater efficiency robustness than a test T 2 if the worst asymptotic relative efficiency of T 1 to the asymptotically optimal test across all genetic models is higher than the worst asymptotic relative efficiency of T 2 . The CATT Z 1/2 optimal for the ADD model is most robust among all trend tests when the genetic models are constrained in Λ. Pearson's test is also robust because it does not require the genetic models to be constrained or the alternative hypothesis to be ordered. When restricting to Λ, tests more robust than Z 1/2 are available. MAX 3 and GMS are two examples. They both have greater efficiency robustness than Pearson's test and Z 1/2 (Freidlin et al., 2002; Zheng and Ng, 2008) . On the other hand, combining information of both Pearson's test and Z 1/2 , MIN2 is also more efficiency robust than either Pearson's test or Z 1/2 . Three robust tests, MAX 3 , GMS and MIN2, appear to have comparable efficiency robustness in candidate-gene studies .
In genome-wide scans it is desirable to locate the SNPs representing true association as near the top as possible, where all SNPs compete for the top ranks. Under the complete LD model, conducted simulation studies comparing the three robust methods in ranking 300,000 SNPs, among which there were 6 functional loci with different genetic models, MAFs and GRRs (from 1.25 to 1.5). The results showed that the GMS slightly outperforms MIN2 and MAX 3 when the top 5000 SNPs were selected. The criteria used for comparison included the probability that the top 5000 SNPs contained at least one SNP with true association, as well as the minimum and average ranks of SNPs with true associations among the top 5000 SNPs. We will conduct similar simulation studies in Section 5 under the inperfect LD model. The reason that we choose the top 5000 SNPs rather than a smaller number, say, the top 100, is that the SNPs with true association are not always ranked near the top, especially for a small GRR between 1.2 and 1.5 and small sample sizes (Zaykin and Zhivotovsky, 2005) . If we examine the top 100 list with 250 cases and 250 controls (the sample sizes that we used in our simulation studies), the probability that the list of the top 100 SNPs contains a true association is less than 0.50.
SIMULATION STUDIES
The GMS Procedure under the Imperfect LD Model
We first conducted simulation studies to estimate the distribution of genetic models selected by the GMS. We chose disease prevalence k = 0.1 and GRR λ * 2 = 2 at the functional locus. Then λ * 1 was obtained using λ * 2 and a given genetic model at the functional locus. We considered 0.1, 0.3 and 0.5 for the equal MAFs at a SNP (p) and a functional locus (q). This allows us to compare the frequencies of the different models selected when D ′ = 1.0, 0.8 and 0.6. With equal allele frequencies p = q, Corr(A, a) = D ′ . In each of 10,000 replicates, 250 cases and 250 controls were simulated from multinomial distributions in which the penetrances at a SNP were calculated using (5) to (7). When the GMS did not select REC or DOM, the ADD or MUL models are used and denoted here by A/M. Results are reported in Table  3 .
When the true model is REC or DOM at the functional locus, the frequencies that the model selected by the GMS at the marker locus is REC or DOM decreases dramatically when D ′ becomes small. For example, when p = q = 0.3, the frequency of selecting REC at the marker locus is about 67.5% when the true model at the functional locus is REC, and D ′ = 1. This frequency declines to 18.6% when D ′ = 0.6. These frequencies, however, are not sensitive when the true model at the functional locus is either ADD or MUL. The findings are consistent with Theorems 2.1 and 2.2. Given the genetic model space Λ * at the functional locus, the genetic model space at the marker locus Λ is shifted toward the center of the space Λ * corresponding to the ADD/MUL models. Table 4 reported the GRRs at the marker locus given those at the functional locus. Note that when Table 4 GRRs (λ1, λ2) at a SNP given GRR λ * 2 = 2 at the functional locus: the true model is ADD (λ * 1 = (1 + λ * 2 )/2) or MUL (λ * 2 1 = λ * 2 ), the GRRs at the marker locus follow the same models. However, λ i are smaller than λ * i . Similar patterns are observed when the true model is REC or DOM, except that λ 1 is slightly greater than λ * 1 under the REC model.
Comparison of Robust Tests in GWAS under
the Imperfect LD Model
In Table 3 when the true model is REC or DOM at the functional locus, the GMS could not select REC or DOM at the marker locus. This, however, does not mean that the GMS cannot improve power or chances of true discoveries when | Corr(A, a)| < 1. On the contrary, owing to the shrinkage of the genetic model space and that the GMS only selects a model at the marker locus, it can be viewed as selecting an appropriately induced model at the marker locus. Our next simulation will examine the performance of robust tests under the imperfect LD model. The simulation procedure follows the one used in . We simulated genotype counts for each of 300,000 SNPs, among which 6 SNPs have true associations and D ′ = 0.8 with MAF of 0.2 at the functional loci. When D ′ = 1, the number of functional loci is also 6. However, when D ′ = 0.8, we assume the number of functional loci equals the number of different genetic models in the simulation. Tables 5 and  6 were 0. 1821, 0.2943, 0.1078, 0.4459, 0.1620 and 0.1825 . These are also given in and in Li et al. (2008b) . MAFs for the rest of the null SNPs were simulated from a uniform distribution U (0.1, 0.5). The GRRs for the functional loci were all 1.25 (or 1.50). We applied five robust tests (Z 1/2 , Pearson's test T χ 2 , GMS, MIN2 and MAX 3 ) to rank all SNPs and the top 5000 SNPs were selected from each of 200 replicates. The criteria to compare the performance of robust tests include the probability (prob %) of at least one true SNP being selected among the top 5000 SNPs, the average number of true SNPs among the top, and the mean of the minimum ranks of the true SNPs among the top. The results are presented in Table 5 (2 REC, 1 ADD, 1 MUL and 2 DOM SNPs) and Table 6 (1 REC, 2 ADD, 2 MUL and 1 DOM SNPs). First, when D ′ = 1 , the GMS outperforms other tests under all three criteria, while Pearson's test had the worst performance. When D ′ = 0.8, however, the GMS and Z 1/2 had similar performances, which together outperform other tests using the three criteria. This finding is consistent to our results in Theorems 2.1 and 2.2 about the genetic models under the imperfect LD model.
APPLICATIONS TO WTCCC DATA
We apply the five robust tests to a genome-wide scan using more than 300,000 SNPs after quality control. The study was originally conducted by WTCCC (2007) for seven diseases (type 1 diabetes-T1D, type 2 diabetes-T2D, coronary heart disease-CHD, hypertension-HT, bipolar disorder-BD, rheumatoid arthritis-RA and Crohn's disease-CD). About 2000 cases were used for each disease and 3000 controls were shared for the seven diseases. WTCCC (2007) used MIN2 to test for association after the quality control. They obtained two tables presenting SNPs with strong associations with MIN2 < 5 × 10 −7 (Table 3 of WTCCC, 2007) and SNPs with moderate associations with 5 × 10 −7 ≤ MIN2 < 5 × 10 −5 (Table 4 of WTCCC, 2007) . We reanalyze these data by ranking all SNPs after our quality control. The goal of this application is to demonstrate the efficiency robustness of different test statistics, not to find SNPs with associations that were not reported in WTCCC (2007).
In our application, for each of the seven diseases, we rank all SNPs after quality control (398,092 SNPs) using the five robust tests and report the ranks of the SNPs that were reported to have strong associations in WTCCC (2007), Table 3 . Note that we do not know D ′ in reality, nor do we know the number of functional loci and their modes of inheritance. Our results are reported in Table 7 . The results show that SNPs with strong associations are all ranked on the top 5000 SNPs. The CATT is least robust among the five robust tests as shown by the rank 269 for BD, while the ranks by the other methods are less than 25. The GMS tends to have smaller ranks than MAX 3 , and MIN2 tends to have ranks between the CATT and Pearson's test, which often have higher ranks than the GMS.
We also studied the ranks of SNPs with moderate associations reported in WTCCC (2007), Table 4 . The detailed results are not shown here, but summarized below. Similar patterns are also observed, although, for several SNPs, the CATT has large ranks. For example, for BD, the CATT has rank 147,769 for SNP rs6458307 on chromosome 6, while the ranks of other tests for this SNP are less than 150. For T2D, the CATT has rank 197,064 for SNP rs358806 on chromosome 3, while the other tests have ranks less than 100. All ranks of SNPs with either strong or moderate associations are less than 5000, and only one SNP (rs17166496 for T1D on chromosome 5) is ranked more than 5000 by MAX 3 and the GMS. The actual ranks for this SNP are 5521 for the GMS (Zheng, Joo and Yang, 2009; Joo et al., 2009 ). In addition, we found that for those SNPs with small ranks based on Pearson's test, a large rank using the CATT is always accompanied by a large value of the HWDTT. This is due to the orthogonal decomposition of Pearson's test to the HWDTT and Z 2 1/2 . It is also interesting to note that, even if a SNP has a rank smaller than those SNPs listed in Table 7 , it does not mean the SNP has a true association with a disease. That is, in GWAS, a SNP with smaller p-value does not necessarily mean it has stronger association. In fact, many of these SNPs with smaller ranks have not been confirmed to have true associations (WTCCC, 2007) . This is because a very small number of SNPs (<100 SNPs) are associated with a disease in GWAS compared to the number of null SNPs (more than 300,000 SNPs). Therefore, the probability that test statistics of some null SNPs are greater than those of all the associated SNPs is high (Zaykin and Zhivotovsky, 2005) . 
